Merck KGaA (MKGAF)
155.45
-0.79
(-0.51%)
USD |
OTCM |
Oct 05, 16:00
Merck Price to Book Value : 1.959 for Oct. 5, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 05, 2026 | 1.959 |
| October 02, 2026 | 1.969 |
| October 01, 2026 | 1.887 |
| September 30, 2026 | 2.066 |
| September 29, 2026 | 2.066 |
| September 28, 2026 | 2.010 |
| September 25, 2026 | 2.010 |
| September 24, 2026 | 1.955 |
| September 23, 2026 | 1.898 |
| September 22, 2026 | 1.890 |
| September 21, 2026 | 1.937 |
| September 18, 2026 | 1.912 |
| September 17, 2026 | 1.895 |
| September 16, 2026 | 1.979 |
| September 15, 2026 | 1.915 |
| September 14, 2026 | 1.983 |
| September 11, 2026 | 1.944 |
| September 10, 2026 | 1.915 |
| September 09, 2026 | 1.982 |
| September 08, 2026 | 1.954 |
| September 04, 2026 | 2.006 |
| September 03, 2026 | 2.100 |
| September 02, 2026 | 2.063 |
| September 01, 2026 | 2.123 |
| August 31, 2026 | 2.042 |
| Date | Value |
|---|---|
| August 28, 2026 | 2.068 |
| August 27, 2026 | 1.993 |
| August 26, 2026 | 2.074 |
| August 25, 2026 | 2.067 |
| August 24, 2026 | 2.060 |
| August 21, 2026 | 2.057 |
| August 20, 2026 | 2.043 |
| August 19, 2026 | 2.061 |
| August 18, 2026 | 2.019 |
| August 17, 2026 | 1.995 |
| August 14, 2026 | 1.999 |
| August 13, 2026 | 2.048 |
| August 12, 2026 | 2.061 |
| August 11, 2026 | 2.061 |
| August 10, 2026 | 2.097 |
| August 07, 2026 | 2.115 |
| August 06, 2026 | 2.117 |
| August 05, 2026 | 2.139 |
| August 04, 2026 | 2.150 |
| August 03, 2026 | 2.080 |
| July 31, 2026 | 2.129 |
| July 30, 2026 | 2.132 |
| July 29, 2026 | 2.095 |
| July 28, 2026 | 2.111 |
| July 27, 2026 | 2.057 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Bayer AG | 1.440 |
| Dermapharm Holding SE | 3.850 |
| AstraZeneca PLC | 10.39 |
| GSK Plc | 4.024 |
| Johnson & Johnson | 7.221 |
Price to Book Value Related Metrics
| PE Ratio | 24.43 |
| PS Ratio | 2.742 |
| Price to Free Cash Flow | 856.66 |
| Price | 155.45 |
| Earnings Yield | 4.09% |
| Market Cap | 67.59B |
| Operating PE Ratio | 13.93 |
| Normalized PE Ratio | 20.72 |